4 Key Reasons Why Hyaluronic Acid Gel Injections Are Used for Nonsurgical Eyelid Rejuvenation

From Subtraction to Restoration: Rethinking Eyelid Rejuvenation Introduction For decades, eyelid rejuvenation was fundamentally subtractive. Traditional blepharoplasty techniques focused on removal—skin excision, muscle tightening, and fat debulking—aimed at reducing redundancy and contour irregularities. While effective in appropriately selected patients, these approaches often failed to account for a critical driver of periorbital aging: volume deflation.

Over the past two decades, aesthetic surgeons have increasingly recognized that the aging face is not simply “excess tissue,” but rather a composite of deflation, descent, and dysregulation of structural support. Nowhere is this more evident than in the periorbital region, where even subtle volume loss can produce disproportionately aged appearances.

The work of Lee and Yen (2017) helped formalize this conceptual shift, demonstrating that hyaluronic acid (HA) gel fillers provide a targeted, minimally invasive method to restore periorbital volume and refine contour without surgical excision. The Aging Periorbital Anatomy: Beyond Skin Laxity Modern periorbital rejuvenation begins with a precise anatomical understanding of aging changes:

1. Upper Eyelid Volume Loss

• Progressive deflation of the superior sulcus

• Exposure of the superior orbital rim

• Deepening of the “hollow eye” appearance

• Coexisting brow descent and dermatochalasis may compound deformity
  

2. Lower Eyelid and Midface Interface

• Weakening of orbital septum → pseudoherniation of fat pads

• Tear trough deformity at the orbitomalar ligament

• Midface descent (SOOF and malar fat pad descent)

• Inferior orbital rim skeletonization
  

3. Key Transition Zones

Particularly important are ligamentous adherence points:

• Orbitomalar ligament (tear trough)

• Malar septum and malar ligament

• Septal confluence region
  

These create fixed depressions that exaggerate shadowing and perceived fatigue, even in relatively young patients.

Figure 1. Bone resorption with age. In this figure, the authors demonstrate the areas of facial skeleton susceptible to bony resorption by aging. The areas with a higher degree of bony resorption are illustrated with larger arrows. Reproduced with permission from Mendelson and Wong

Figure 2. Images of a patient: both eyes (A), left eye and (B), right eye (C) with pseudoherniation of the lower eyelid fat pads, midface deflation, and descent of the suborbicularis oculi fat and malar fat pads, leading to increased exposure of the orbital rim.

---

Why Hyaluronic Acid? Biologic and Rheologic Rationale Hyaluronic acid (HA) fillers are uniquely positioned for periorbital rejuvenation because their performance is not defined solely by volumization, but by a combination of biological compatibility and tunable viscoelastic behavior. Modern filler science increasingly treats HA as a material system rather than a uniform injectable, with clinical behavior predicted by measurable rheologic parameters such as elastic modulus (G′), viscosity (G″), cohesivity, and swelling factor. 1. Biologic Rationale: Why HA is inherently suited for periorbital tissue

1.1 Endogenous presence and immunologic safety

Hyaluronic acid is a linear glycosaminoglycan composed of repeating disaccharides of D-glucuronic acid and N-acetyl-D-glucosamine. It is a ubiquitous component of the extracellular matrix in skin, vitreous body, and synovial fluid, contributing to hydration, viscoelasticity, and tissue homeostasis.

Because HA is:

• Structurally identical across species (non-species-specific antigenicity)

• Devoid of protein-based epitopes when properly purified

• Naturally degraded by hyaluronidase pathways
  

It demonstrates an exceptionally low immunogenic profile, which is a key advantage in high-visibility, high-risk areas such as the periorbita.

Clinical reviews consistently report very low rates of hypersensitivity reactions compared with earlier collagen-based fillers, supporting its safety profile for facial augmentation applications.

1.2 Physiologic integration in dermal and periorbital ECM

In the periorbital region, HA functions not merely as a space-occupying gel but as a hydration and scaffolding analog of native extracellular matrix (ECM).

Its hydrophilic nature:

• Promotes controlled water binding within interstitial spaces

• Enhances dermal turgor without rigid structural distortion

• Allows gradual enzymatic turnover via endogenous hyaluronidase
  

This dynamic integration is particularly relevant in eyelid skin, which is among the thinnest in the human body (≈0.3–0.5 mm) and highly sensitive to irregularities. 2. Rheologic Rationale: Why “mechanical engineering” determines clinical behavior

Parameter	Definition	Mechanical Meaning	Clinical Interpretation in HA Fillers	Periorbital Relevance
G′ (Elastic Modulus)	Measure of elastic energy storage under deformation	Resistance to compression; “firmness” or “lift capacity”	High G′ = strong structural support and projection; Low G′ = soft, pliable gel	High G′ preferred for deep support (e.g., supraperiosteal orbital rim). Low G′ preferred for superficial blending to avoid visibility
G″ (Viscous Modulus)	Measure of energy loss as flow under shear stress	Determines spreadability and internal friction	High G″ = more flow and adaptability; Low G″ = more resistance to spreading	Moderate G″ ideal in tear trough to balance integration vs migration
Cohesivity	Degree of internal adhesion between HA chains	Ability of gel to remain intact vs fragment in tissue	High cohesivity = smooth, homogeneous integration; Low cohesivity = particulate behavior with less uniform spread	High cohesivity critical in thin eyelid skin to reduce lumpiness and Tyndall effect
G* (Complex Modulus)	Combined measure of elastic + viscous behavior (overall stiffness)	Global resistance to deformation	High G* = firmer, more structural filler; Low G* = softer, more diffusive filler	Guides depth selection: high G* deep plane; low G* superficial periocular refinement

2.1 Elastic modulus (G′): depth and lifting capacity

High G′ fillers resist deformation and maintain structural projection against compressive forces.

• High G′ → deep plane volumization (bone, deep fat compartments)

• Low G′ → superficial integration and fine correction
  

Rheologic analyses show that fillers such as NASHA-based gels (e.g., Restylane family) tend to have higher elastic behavior and structural integrity, making them suitable for deeper placement and contour definition.

In contrast, lower G′ gels (e.g., Vycross or CPM-based systems) are engineered for tissue pliability and smoother surface blending. 2.2 Cohesivity: critical determinant in the tear trough

Cohesivity describes the internal adhesive force between HA chains, influencing whether a gel:

• Remains localized as a bolus

• Spreads uniformly through tissue planes

• Resists fragmentation under dynamic facial motion
  

A landmark comparative analysis demonstrated that:

• Monophasic polydensified gels (e.g., Belotero Balance) exhibit high cohesivity and tissue integration

• NASHA-based products (e.g., Restylane) demonstrate lower cohesivity but higher structural stability

• Intermediate products (e.g., Juvéderm Hylacross/Vycross) fall between these extremes
  

Clinical implication:

In the periorbital region, where the dermis is thin and vascular structures are superficial, cohesivity directly influences:

• Risk of visible nodularity

• Tyndall effect incidence

• Homogeneity of light reflection under thin skin

2.3 Viscosity and tissue spreading behavior

Viscosity (G″) governs how a filler spreads under mechanical stress.

• High viscosity → controlled placement, reduced migration

• Low viscosity → smoother diffusion, improved blending in superficial planes
  

However, excessive viscosity in the tear trough can lead to:

• Palpable irregularities

• Poor integration under thin dermis
  

Thus, optimal periorbital fillers require a balanced viscoelastic profile rather than extreme values of either parameter.

2.4 Swelling factor and hydrophilic behavior

One of the most clinically relevant but underappreciated properties is post-injection water uptake.

HA fillers are hygroscopic, and swelling depends on:

• Crosslink density

• HA concentration

• Ionic environment of tissue
  

Excess swelling in the periorbital region contributes to:

• Post-injection edema

• Malar edema persistence

• “Overfilled” lower lid appearance
  

This is why modern filler design increasingly targets controlled water absorption profiles rather than maximal volumization alone. 3. Product-Specific Behavior: Why not all HA fillers behave the same

3.1 NASHA technology (e.g., Restylane family)

• Particle-based gel structure

• Higher G′ (firmness, projection)

• Lower cohesivity relative to monophasic gels

• Strong structural definition
  

Clinical implication:

• Better for deep tear trough support or ligament-adjacent placement

• Higher risk of visible irregularity if placed too superficially
  

3.2 Hylacross / Vycross systems (e.g., Juvéderm Ultra, Volbella)

• More homogeneous gel matrix

• Increased crosslink efficiency

• Lower G′ (softer feel)

• Higher cohesivity relative to NASHA
  

Clinical implication:

• Improved surface smoothing and transition zones

• Increased risk of edema in patients prone to lymphatic congestion
  

3.3 Polydensified cohesive gels (e.g., Belotero)

• High tissue integration capability

• Low light scattering in superficial dermis

• Exceptional adaptability in thin skin planes
  

Clinical implication:

• Preferred for very superficial periorbital rhytids or fine tear trough blending

• Lower risk of Tyndall effect when correctly placed
  

4. Clinical Synthesis: Why product selection is anatomical, not preferential

Modern filler science strongly supports the concept that no single HA filler is universally optimal for the periorbital region.

Instead, selection should be based on:

• Depth of defect (deep vs superficial)

• Skin thickness and translucency

• Lymphatic drainage capacity

• Dynamic muscular activity

• Risk tolerance for edema or visibility
  

This aligns with rheologic literature demonstrating that G′, cohesivity, and viscosity must be matched to anatomical layer biomechanics rather than aesthetic preference alone.

---

Patient Selection: The Determinant of Success

Domain	Ideal Candidates (Favorable Anatomy/Physiology)	Caution / Poor Candidates (High Risk or Suboptimal Response)	Clinical Implications for HA Treatment
Primary deformity pattern	Volume depletion (tear trough hollowing, superior sulcus deflation) as dominant feature	Skin redundancy, dermatochalasis, significant orbital fat prolapse	HA is effective for restoring volume loss but does not correct excess skin or true herniation
Skin laxity	Minimal to mild laxity with good dermal elasticity	Moderate to severe laxity with crepey or redundant eyelid skin	High laxity increases risk of irregular contour and suboptimal aesthetic blending
Lower eyelid morphology	Mild tear trough deformity without prominent festoons	Pronounced festoons, malar edema, or chronic fluid accumulation	Festoons and malar bags often worsen with filler due to fluid shift and lymphatic compromise
Lymphatic function	Intact lymphatic drainage; no history of chronic periorbital edema	Baseline edema-prone anatomy, impaired lymphatic drainage, malar edema tendency	HA hydrophilicity can exacerbate persistent swelling in compromised lymphatic systems
Midface support	Mild to moderate midface descent with preserved malar support	Severe midface descent with ligament laxity and heavy malar bags	Severe descent often requires surgical midface lifting rather than filler camouflage
Tissue thickness	Moderate dermal thickness allowing controlled integration	Extremely thin, translucent skin prone to Tyndall effect	Thin skin increases risk of visible filler, especially with superficial placement
Inflammatory status	No active dermatitis or periorbital inflammation	Active inflammatory skin disease, rosacea flares, or infection	Inflammation increases complication risk and unpredictable filler behavior
Aesthetic expectation	Realistic expectation of subtle improvement and non-surgical correction limits	Desire for surgical-level correction without surgery	Overexpectation correlates strongly with dissatisfaction even in technically successful cases

Core Diagnostic Distinction

Category	Pathophysiology	Response to HA Fillers
“Hollowing pathology”	True volume depletion (fat pad atrophy, skeletal rim exposure, ligament-related depressions)	Predictable, high-response; ideal indication for HA restoration
“Redundancy pathology”	Excess skin, fat prolapse, festoons, or tissue laxity	Poor response; often worsened or only partially masked by fillers

---

Figure 3. Pretreatment (A) and posttreatment images (B) of a patient who was treated with hyaluronic acid gel and chemical peel to the bilateral lower eyelid area.

Injection Strategy: Precision in a High-Risk Anatomical Zone

Periorbital filler delivery demands submillimetric precision and deep anatomical awareness.

General Principles

• Avoid anesthetic distortion (limit infiltration)

• Prefer topical or cold-based analgesia

• Use small aliquots (typically 0.1–0.5 mL per region)

• Maintain linear, feathered deposition patterns

• Avoid bolus placement
  

Upper Eyelid Technique

• Entry at superolateral orbital rim

• Suborbicularis or supraperiosteal plane

• Micro-aliquots (~0.1 mL)

• Linear threading with gentle molding

Critical caution: avoid supraorbital neurovascular structures and overcorrection, which rapidly produces visible contour irregularities. Lower Eyelid / Tear Trough Technique

• Suborbicularis oculi fat plane over inferior orbital rim

• Linear retrograde deposition

• Feathered layering technique

• Volume range: ~0.3–0.5 mL depending on deformity

Key technical principle:

Diffuse plane spread > focal deposition

Post-injection molding is essential due to the thin dermis and high risk of Tyndall effect.

---

Complications: Predictable but Manageable While HA fillers are considered high-safety agents, the periorbital region introduces unique risks.

Common Events

• Edema (often delayed due to hydrophilic nature)

• Bruising and erythema

• Contour irregularities

• Tyndall effect (bluish discoloration)
  

Dose-Related Issues

• Overcorrection → persistent puffiness

• Under-correction → masked early by edema
  

Management Principle

Wait for edema stabilization before judging final volume effect (typically several days to 2 weeks). Reversibility Advantage: A Key Safety Net

Unlike surgical interventions, HA-based rejuvenation offers complete reversibility via hyaluronidase.

Indications:

• Overfilling

• Irregular contour

• Persistent edema

• Vascular compromise (urgent)
  

This reversibility significantly expands procedural safety margins, particularly for early-career injectors.

Rare but Critical Complications

Although uncommon, serious vascular events require immediate recognition:

• Arterial occlusion → blanching, pain, immediate onset

• Venous compromise → delayed swelling and discoloration

• Extremely rare retinal artery embolization → vision-threatening emergency

Management includes:

• Massage and warm compresses

• Vasodilatory measures (e.g., nitroglycerin paste)

• Hyaluronidase administration when indicated
  

Preventive strategy remains paramount:

Linear threading + small aliquots + avoidance of high-pressure bolus injection

Clinical Implications: The New Rejuvenation Algorithm

Modern periorbital rejuvenation is no longer binary (surgery vs no surgery). Instead, it is layered:

1. Neurotoxins → dynamic wrinkle modulation

2. HA fillers → volume restoration

3. Energy devices / resurfacing → skin quality improvement

4. Blepharoplasty (selective) → structural excess correction
   

This multimodal framework allows customized anatomical correction rather than uniform surgical excision.

Figure 4. Hyaluronic acid injection to the tear trough and malar eminences: (A) pre-injection; and (B) post-injection to the infraorbital hollows with 1 mL of Volbella XC on each side as well as 1 mL of Voluma XC to each malar and infraorbital region

Conclusion The evolution of periorbital rejuvenation reflects a fundamental paradigm shift in aesthetic medicine, moving from a reductive surgical philosophy toward a restorative, volume-centric approach.

Hyaluronic acid gel fillers have become a cornerstone in this transition due to their predictable clinical performance, tunable rheologic properties, consistently high patient satisfaction, and favorable safety profile, including reversibility with hyaluronidase.

When employed with rigorous anatomical assessment and precise, plane-specific injection technique, HA fillers can effectively restore superior sulcus volume, soften the appearance of inferior orbital rim skeletonization, attenuate tear trough shadowing, and re-establish smoother, more youthful periorbital transitions.

Ultimately, optimal outcomes are determined less by the intrinsic properties of the filler itself and more by the clinician’s ability to conceptualize the periorbital region as a dynamic, multidimensional volume-deficient system rather than a static zone of tissue redundancy requiring excision. Reference:

• Lee, S., & Yen, M. T. (2017). Nonsurgical rejuvenation of the eyelids with hyaluronic acid gel injections. Seminars in Plastic Surgery, 31(1), 17–21.

---

Learn cutting-edge Korean filler techniques for refined, full-face enhancement of the lips, tear trough, midface, chin, and jawline.

IFAAS Mini Fellowship (Hands-On)​

Korean Tailored Aesthetic Injections: Lip Augmentation, Eye Rejuvenation & Facial Contouring

20-21 August, 2026 - Seoul, South Korea  - [Register Now]

---

More Upcoming Global Events

Global Event Calendar